Neonatal bone marrow transplantation in MPS IIIA Mice

JIMD Reports

Volumn 8, Issue , 2013, Pages 121-132

  Lau, Adeline A ^a,c   Shamsani, N Jannah ^a,b,c,d   Winner, Leanne K ^a   Hassiotis, Sofia ^a   King, Barbara M ^a   Hopwood, John J ^a,b,c   Hemsley, Kim M ^a,b,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Bone marrow transplantation; Donor cell; Green fluorescent protein; Heparan sulfate; Neutrophil elastase

Indexed keywords

EID: 84896115756     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2012_169     Document Type: Chapter

References (39)

1. Bhattacharyya R, Gliddon B, Beccari T et al (2001) A novel missense mutation in the lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant. Glycobiology 11:99–103
2. Bhaumik M, Muller VJ, Rozaklis T et al (1999) A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology 9:1389–1396
3. Biffi A, De Palma M, Quattrini A et al (2004) Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest 113:1118–1129
4. Birkenmeier EH, Barker JE, Vogler CA et al (1991) Increased life span and correction of metabolic defects in murine mucopoly-saccharidosis type VII after syngeneic bone marrow transplantation. Blood 78:3081–3092
5. Cardone M, Porto C, Tarallo A et al (2008) Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts. Pathogenetics 1:6
6. Clancy B, Darlington RB, Finlay BL (2001) Translating developmental time across mammalian species. Neuroscience 105:7–17
7. Cogle CR, Yachnis AT, Laywell ED et al (2004) Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 363:1432–1437
8. Crawley AC, Gliddon BL, Auclair D et al (2006) Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Res 1104:1–17
9. Enquist IB, Bianco CL, Ooka A et al (2007) Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci U S A 104:17483–17488
10. Fraldi A, Hemsley K, Crawley A et al (2007) Functional correction of CNS lesions in a MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Hum Mol Genet 16:2693–2702
11. Frommherz KJ, Faller B, Bieth JG (1991) Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor. J Biol Chem 266:15356–15362
12. Heldermon CD, Ohlemiller KK, Herzog ED et al (2010) Therapeutic Efficacy of Bone Marrow Transplant, Intracranial AAV-mediated Gene Therapy, or Both in the Mouse Model of MPS IIIB. Mol Ther 18:873–880
13. Hemsley KM, Luck AJ, Crawley AC et al (2009) Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease. Eur J Neurosci 29:1197–1214
14. Hoogerbrugge PM, Poorthuis BJ, Romme AE et al (1988) Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest 81:1790–1794
15. Hopwood JJ, Elliott H (1982) Diagnosis of Sanfilippo A syndrome by estimation of sulphamidase activity using a radiolabelled tetra-saccharide substrate. Clin Chim Acta 123:241–250
16. Joshi M, Keith Pittman H, Haisch C et al (2008) Real-time PCR to determine transgene copy number and to quantitate the bioloc-alization of adoptively transferred cells from EGFP-transgenic mice. Biotechniques 45:247–258
17. Klein K, Krivit W, Whitley C et al (1995) Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment. Bone Marrow Transplantation 15:S176–S181
18. Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61:307–330
19. Langford-Smith A, Wilkinson FL, Langford-Smith KJ et al (2012) hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA Mice. Mol Ther doi:10.1038/mt.2012.82
20. Lau AA, Crawley AC, Hopwood JJ et al (2008) Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice. Behav Brain Res 91:130–136
21. Lau AA, Hannouche H, Rozaklis T et al (2010) Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice. Exp Neurol 225:445–454
22. Lawson LJ, Perry VH, Dri P et al (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151–170
23. Lawson LJ, Perry VH, Gordon S (1992) Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48:405–415
24. Levesque JP, Takamatsu Y, Nilsson SK et al (2001) Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98:1289–1297
25. Lin D, Donsante A, Macauley S et al (2007) Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Mol Ther 15:44–52
26. Neufeld EF, Cantz MJ (1971) Corrective factors for inborn errors of mucopolysaccharide metabolism. Ann N Y Acad Sci 179:580–587
27. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR (ed) The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill, pp 3421–3452
28. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
29. Prasad V, Mendizabal A, Parikh S et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979–2989
30. Sands MS, Barker JE, Vogler C et al (1993) Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 68:676–686
31. Sands MS, Erway LC, Vogler C et al (1995) Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Blood 86:2033–2040
32. Schaefer BC, Schaefer ML, Kappler JW et al (2001) Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell Immunol 214:110–122
33. Shapiro EG, Lockman LA, Balthazor M et al (1995) Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 18:413–429
34. Simard AR, Rivest S (2004) Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. Faseb J 18:998–1000
35. Sivakumur P, Wraith JE (1999) Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling. J Inherit Metab Dis 22:849–850
36. Sutherland LS, Hemsley KM, Hopwood JJ (2008) Primary culture of neural cells isolated from the cerebellum of newborn and adult mucopolysaccharidosis type IIIA mice. Cell Mol Neurobiol 28:949–959
37. Villegas J, McPhaul M (2005) Establishment and culture of human skin fibroblasts. Curr Protoc Mol Biol Chapter 28:Unit 28 3.
38. Yogalingam G, Bonten EJ, van de Vlekkert D et al (2008) Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 15:74–86
39. Zheng Y, Ryazantsev S, Ohmi K et al (2004) Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Mol Genet Metab 82:286–295